Autolus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Autolus Therapeutics granted inducement awards to 13 new employees, consisting of options to purchase 25,420 ADSs and 87,530 restricted stock units. The awards were approved under Nasdaq Listing Rule 5635(c)(4) with an exercise price of $1.66 per share, equal to the closing price on June 23, 2026.
Key figures
- Grant date
- June 24, 2026
- Rsus granted
- 87530
- New employees
- 13
- Exercise price
- 1.66
- Options granted
- 25420
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.